Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merck RSV therapy cuts respiratory infections by 60% in infants
Merck’s (NYSE:MRK) monoclonal antibody clesrovimab, designed as a prophylactic against respiratory syncytial virus (RSV), has reduced the RSV-associated lower respiratory infections by roughly 60% in a Phase 2/3 trial for infants.
Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants
Merck announces positive results from Phase 2b/3 and interim Phase 3 trials of a monoclonal antibody designed to protect infants from RSV.
Merck's RSV antibody for infants effective in reducing some types of infections in study
Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some types of respiratory syncytial virus (RSV)-associated infections in infants.
Opinion
1d
Opinion
It’s Always Virus Season Now
Health officials would like to remind you that we are entering that time of the year still quaintly known as flu season. That ...
Business Wire
22h
Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease …
Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...
WKRG Mobile on MSN
2d
Discussing the rise of Respiratory syncytial virus cases in Mobile
More RSV cases are being reported in Mobile. It’s something you may not think much about unless you have children, but adults ...
ConsumerAffairs
3d
RSV gets no respect although it is a common virus and can be severe
RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...
Channel NewsAsia Singapore
3d
More than just a cold: Understanding the respiratory syncytial virus
Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...
9d
Respiratory virus season is back. Here's how to protect against flu, COVID-19 and RSV
Flu, COVID-19 and RSV are predicted to cause about as many hospitalizations as last year. Houston experts offer tips for ...
Medindia
6d
New Signs of Severe Respiratory Syncytial Virus Cases in Kids
Rising cases of severe respiratory syncytial virus (RSV) in kids show new warning signs, highlighting the need for increased ...
3d
DPH encourages vaccinations to stay healthy during respiratory disease season
RSV is a common respiratory virus that infects the nose, throat and lungs. RSV symptoms make it difficult to distinguish it ...
6d
Signs tied to severe cases of respiratory syncytial virus in kids identified
A team of researchers has identified signs tied to more severe cases of respiratory syncytial virus (RSV) in children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
RSV
COVID-19
clesrovimab
Brigham and Women's Hospital
Natural killer cell
Feedback